CLINICAL_TRIALS
trial_result
· 2014-11-26
Clinical Trial Update: Gadobutrol Pharmacokinetic and Safety Study in Pediatric Subjects Aged <2 Years (Term Newborn Infants to Toddlers 23 Months of Age Inclusive) [Phase 1]
Summary
Phase 1 pharmacokinetic and safety study of gadobutrol in pediatric subjects under 2 years old completed; results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Bayer | Conditions: Magnetic Resonance Imaging | Phase 1 | Status: COMPLETED | Results posted: 2014-11-26